Date | Analyst | Company | Last | Target | Call | Valuation |
02/17/23 | UOB Kay Hian | Delfi | 0.9 | 1.42 | Buy | PER17x FY23 |
02/17/23 | Kim Eng | ESR-Reit | 0.35 | 0.45 | Buy | |
02/17/23 | Kim Eng | Frencken | 1.21 | 1.35 | Buy | |
02/17/23 | phillip | Prime US Reit | 0.445 | 0.7 | Buy | DDM |
02/17/23 | UOB Kay Hian | Singtel | 2.47 | 3.15 | Buy | DCF |
02/17/23 | CIMB | Singtel | 2.47 | 3 | Add | |
02/17/23 | DBS Vickers | UMS | 1.16 | 1.74 | Buy | PER11x FY23 |
Friday, February 17, 2023
Stock calls for 17 February 2023
Singapore NODX declined by a whopping 25% in January 2023.
May 2022: 12.4%
April 2022: 6.4%
March 2022: 7.7%
February 2022: 9.5%
January 2022: 17.6%
December 2021: 18.4%
November 2021: 24.2%
October 2021: 17.9%
September 2021: 12.3%
August 2021: 2.7%
July 2021: 12.7%
June 2021: 15.9%
May 2021: 8.8%
April 2021: 6%
March 2021: 12.1%
February 2021: 4.2%
January 2021: 12.8%
December 2020: 6.8%
November 2020: -4.9%
October 2020: -3.1%
September 2020: 5.9%
August 2020: 7.7%
July 2020: 6%
June 2020: 16.1% (Revised to 13.9%)
May 2020: -4.6%
April 2020: 9.7%
March 2020: 17.6%
February 2020: 3% (Revised to 3.1%)
January 2020: - 3.3%
December 2019: 2.4%
November 2019: - 5.9%
October 2019: - 12.3%
September 2019: -8.1%
August 2019: - 8.9%
July 2019: -11.2%
June 2019: -17.3%
May 2019: -15.9%
April 2019: -10%
March 2019: -11.7%
February 2019: 4.9%
January 2019: -10.1%
December 2018: -8.5%
November 2018: -2.6%
October 2018: 8.3%
September 2018: 8.3%
August 2018: 5%
July 2018: 11.8% (Corrected)
June 2018: 1.1%
May 2018: 15.5%
April 2018: 11.8%
March 2018: -2.7%
February 2018: -5.9%
January 2018: 13%
December 2017: 3.1%
November 2017: 9.1%
October 2017: 20.9%
September 2017: -1.1%
August 2017: 16.7%
July 2017: 8.5%
June 2017: 8.2%
May 2017: -1.2%
Apr 2017: -0.7%
Mar 2017: 16.5%
Feb 2017: 21.1%
Thursday, February 16, 2023
Singapore O&G - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
03/08/22 | Lim & Tan | Singapore o&g | 2.5 | 0 | Accept offer |
Singapore Medical - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
03/10/22 | UOB Kay Hian | Singapore Medical | 0.305 | 0.53 | Buy | PER14x FY22 |
04/28/22 | Lim & Tan | Singapore Medical | 0.33 | 0.5 | Buy | |
07/07/22 | UOB Kay Hian | Singapore Medical | 0.3 | 0.53 | Buy | |
08/31/22 | Lim & Tan | Singapore Medical | 0.315 | 0.43 | Buy | |
09/22/22 | UOB Kay Hian | Singapore Medical | 0.365 | 0.45 | Reject offer | PER14x FY22, Offer @ $0.38 |
10/19/22 | Lim & Tan | Singapore Medical | 0.365 | 0 | Accept offer | |
11/03/22 | Lim & Tan | Singapore Medical | 0.38 | 0.43 | Accept offer | Revised offer $0.40 |
11/09/22 | UOB Kay Hian | Singapore Medical | 0.39 | 0.45 | Accept offer | Revised offer $0.40 |
Sin Heng - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
11/18/22 | Lim & Tan | Sin Heng | 0.45 | 0.75 | Buy |
Stock calls for 16 February 2023
Date | Analyst | Company | Last | Target | Call | Valuation |
02/16/23 | Phillip | BRC Asia | 1.84 | 2.14 | Buy | PER7x FY23 |
02/16/23 | DBS Vickers | CSE Global | 0.375 | 0.38 | Hold | |
02/16/23 | Lim & Tan | CSE Global | 0.375 | 0.41 | Neutral | |
02/16/23 | UOB Kay Hian | Ifast Corp | 5.53 | 5.06 | Hold | PER42x FY23 |
02/16/23 | CIMB | Ifast Corp | 5.53 | 3.5 | Sell | |
02/16/23 | Citi Research | Ifast Corp | 5.53 | 3.8 | Sell | |
02/16/23 | OCBC | Netlink | 0.87 | 0.98 | Buy | |
02/16/23 | Kim Eng | Netlink | 0.87 | 0.95 | Buy | |
02/16/23 | Citi Research | Netlink | 0.87 | 0.95 | Buy | |
02/16/23 | OCBC | Sembcorp Marine | 0.135 | 0.185 | Buy | PB1.5x |
02/16/23 | Phillip | Silverlake | 0.355 | 0.49 | Buy | PER20x FY23 |
02/16/23 | Lim & Tan | Singtel | 2.45 | 0 | Buy |